The webcast can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in
Contact Information: Patricia A. Spinella, Investor Relations - 201-847-5453 Colleen T. White, Corporate Communications -201-847-5369
SOURCE BD (Becton, Dickinson and Company)